Jump to content

Speakers


Professor Timothy Barrett, University of Birmingham, UK

Professor Timothy Barrett trained in paediatrics in London and Exeter, and undertook a PhD in human genetics in University of Birmingham. His research interests include the delineation of rare diabetes syndromes, and he has a laboratory and translational research programme investigating therapeutic strategies for Wolfram syndrome. He leads the NIHR TRC-RD cross cutting Paediatrics theme, and is Programme Director for the NIHR Wellcome Clinical Research Facility (Children) at Birmingham Children’s Hospital. He is active clinically as honorary consultant in paediatric endocrinology and diabetes, and leads 3 NHSE highly specialised services, for Wolfram, Alstrom, and Bardet Biedl syndromes.
Dr Nigel Beckett, Guys And St Thomas' NHS Trust

Dr Beckett is a Consultant Geriatrician at St Thomas’ Hospital. Roles include, Joint Clinical Director for Integrated Therapies and Medicine Directorate; clinical lead for acute frailty, mortality lead for GIM and lead for South London LCRN (Ageing). Research focus is CVD in older adults, particularly hypertension. Away from medicine looks after 2 retired greyhounds.
Professor Michel Burnier, University of Lausanne, Switzerland

M. Burnier is Emeritus Professor at the University of Lausanne where he is has been the Head of Nephrology and Hypertension for 14 years Member of the council of the ESH for many years, his main research interests are the role of salt in the pathophysiology of hypertension, the pharmacological development of new antihypertensive drugs and drug adherence.
Professor Chris Byrne, University of Southampton, UK


Professor Byrne trained in the UK and the US, at Cardiff, Cambridge and Stanford Universities. Prof Byrne was appointed in 1999 to the Chair of Endocrinology & Metabolism at the University of Southampton and has published over 300 peer reviewed papers related to metabolic syndrome and non-alcoholic fatty liver disease.
Professor Francesco Cappuccio, University of Warwick, Coventry, UK

Professor Cappuccio holds the Cephalon Chair in Cardiovascular Medicine & Epidemiology at Warwick Medical School and is Consultant Physician at the University Hospital Coventry & Warwickshire NHS Trust. He is currently the President of the British and Irish Hypertension Society, Director of the European Society of Hypertension Centre of Excellence in Coventry and Head of the World Health Organization Collaborating Centre. His research interests are the epidemiology of cardiovascular disease, nutrition and health (with major interest in the roles of salt and potassium in the determination of population risk), metabolic abnormalities and cardiovascular risk, risk in ethnic minorities, both in developed and developing countries. He has also developed an international programme in sleep epidemiology, studying the long term population effects of sleep deprivation. He authored nearly 500 publications (h-index: 81)
Professor Lucy Chappell, King’s College, UK

Professor Lucy Chappell is NIHR Research Professor in Obstetrics at King’s College London and Honorary Consultant Obstetrician at Guy’s and St Thomas’ NHS Foundation Trust, running a research programme investigating prediction and prevention of adverse pregnancy outcomes, particularly in women with pre-existing co-morbidities such as chronic hypertension and chronic kidney disease.
Professor Lyne Cloutier, Université du Québec à trois - revières, Canada

Lyne Cloutier is a full professor in the department of nursing of the Université du Québec à Trois-Rivières in Canada. She holds a PhD in clinical science from Université de Sherbrooke and pursued post-doctoral studies in pharmacology at the Université de Montréal. Her research program is mainly focused on hypertension management and she has received research grants for diverse organizations (FRSQ, CIHR, AUF). She was president of the Quebec society of hypertension and is co-chair of the Canadian Hypertension Canada guidelines for blood pressure measurement. She authored and collaborated to 100 scientific papers and has presented 150 conferences mainly on hypertension and blood pressure measurement.
Mrs Elizabeth Denver, Whittington Health NHS Trust, UK

Elizabeth is the Hypertension Nurse Member of the NICE Guidelines Committee reviewing Hypertension in adults. She qualified in 1977 and later became a diabetes and cardiovascular research Nurse. In 2000 she started a Nurse-Led Hypertension Clinic. Elizabeth is a member of the BIHS Blood Pressure Measurement and AHP Working Parties.
Professor Caroline Fall, University of Southampton, UK

Professor Caroline Fall is a paediatrician and epidemiologist at the University of Southampton. Her research focuses on the early life origins of cardiovascular disease and type 2 diabetes, through studies linking maternal nutrition, fetal development and CVD risk markers in children. Most of her current research is in low- and middle-income countries.
Dr Mark Glover, Nottingham, UK

Mark trained in pre-clinical pharmacology and clinical medicine at Gonville and Caius College, Cambridge. His clinical and research interests are in hypertension and the identification of novel anti-hypertensive drug targets by understanding the molecular pathophysiology of sodium reabsorption in the distal nephron. He leads the hypertension clinic in Nottingham.
Mark’s current research is focussed on the molecular pathophysiology of sodium reabsorption via the thiazide-sensitive pathway, based on genetic analysis of individuals with the Mendelian Gordon syndrome and Thiazide-Induced Hyponatraemia in those with essential hypertension.
Mark’s other interests are in medical education and general (internal) medicine. He is a member of the Prescribing Safety Assessment Board for UK medical students, an associate member of the Higher Education Academy, a member of NICE Technology Appraisal Committee B, the NICE hypertension in adults guideline committee and the MHRA Pharmaco-vigilance committee.
Professor Philip Kalra

Professor Philip Kalra has a major research focus on renovascular disease, cardiovascular disease in CKD and the progression and epidemiology of non-dialysis CKD. He is Academic Vice President of the UK Renal Association and was NIHR CRN Renal Disorders Chair until late 2018.
Professor Janet Lord, Birmingham University, UK

Professor Janet Lord is director of the Institute of Inflammation and Ageing at Birmingham University, she is also director of the MRC-ARUK Centre for Musculoskeletal Ageing Research. Her main research interest is how inflammation drives the ageing process and lead to frailty and multimorbidity and how to minimise ageing processes.
Miss Judith Magowan,

Miss Judith Magowan works as a prescribing nurse in Primary Care where she is the Long Term Condition lead. She set up their nurse-led hypertension clinic in 2010. Since completing a post graduate certificate in education in 2009, she has worked as an associate lecturer developing and delivering modules, study days and updates on asthma, COPD and Spirometry, cardiovascular disease and hypertension. Miss Magowan has been delivering a BIHS approved study day on nurse-led hypertension across Devon and Cornwall through the Community Education Network Provider.
Professor Richard Mcmanus, Oxford, UK

Richard McManus is Professor of Primary Care Research and a part time GP in Oxford. His research interests lie mainly in the prevention of cardiovascular disease with particular emphasis on blood pressure measurement and management of hypertension in primary care where his work has influenced National and International Clinical Guidelines.
Dr Sunil Nadar, Sultan Qaboos University Hospital, Oman

Dr Nadar is a consultant interventional cardiologist at the Sultan Qaboos University Hospital. He is also the editor with Journal of Human Hypertension.
Professor Gianfranco Parati, St Luca Hospital, Italy

Head, Dept Cardiology St Luca Hospital, Milan; Scientific Director, Istituto Auxologico Italiano, Milan; Professor of Cardiovascular Medicine, University of Milano-Bicocca, Milan, Italy. Past President, Italian Society of Hypertension. Past Chairman, ESH working groups on Blood pressure monitoring and blood pressure variability. Fellow of the European Society of Cardiology. Liaison Officer, Nucleus Board of ESC Council on Hypertension. Secretary general and Executive Board Member, WHL

Dr Terry Quinn, University of Glasgow, UK

Dr Terry Quinn is Senior Clinical Lecturer and Honorary Consultant based in the Institute of Cardiovascular and Medical Sciences, University of Glasgow. Terry has a broad research portfolio. Research interests include trial methodology, functional/cognitive assessment and neuropsychological consequences of cardiovascular disease. He has published over 150 papers with recent titles in BMJ, JAMA and NEJM.

Terry has various editorial board positions, including coordinating editor of the Cochrane Dementia Group. He is part of the NIHR Complex Reviews Support Group; chairs the stroke psychology SIG of the World Federation of Neuropsychology and is founder and past chair of the Scottish Care-Home Research Group. He provides clinical expertise to the Scottish Parliament Heart and Stroke Disease Cross-Party Group and Healthcare Improvement Scotland.
Terry’s work has always maintained a clinical focus. He combines research with teaching and clinical commitments in the stroke wards of Glasgow Royal Infirmary.
Professor David Ray, University of Oxford, UK

David trained in general internal medicine in North West England, and obtained a PhD from the University of Manchester. He was a research fellow at UCLA for two years, working on neuroendocrine-immune interaction, before returning to the UK, and obtaining a GSK fellowship to work on glucocorticoid action, and sensitivity in inflammatory disease. He was promoted to Professor of Medicine at the University of Manchester in 2005, and went on to study nuclear receptor and circadian biology in inflammation, and energy metabolism. This work attracted Wellcome Investigator and MRC programme grant support.
David is a passionate advocate of research training, serving on the MRC clinical fellowship panel for seven years, three as deputy chair.
Circadian mechanisms regulate most mammalian physiology, with particular importance in the regulation of innate immunity, through the macrophage in particular, and energy metabolism, regulating liver, adipose and muscle. These circuits are also regulated by a number of nuclear receptors, which show a striking interdependency on the circadian machinery; some having ligand availability regulated by the clock, others varying in expression level through the day. We have employed a range of approaches to address the physiological importance of the circadian:nuclear receptor system, ranging from population genetics, experimental medicine studies, CRISPR engineered mice, and cell biology. These approaches have discovered how the important dimension of time regulates metabolism, and coordinates diverse tissues to deliver optimal organismal performance. Importantly, we are identifying how external stressors can decouple these systems, with deleterious effects.
Dr James Sheppard, University of Oxford, UK

James is a Population Health Scientist interested in better understanding the benefits and harms of treatments, with a particular focus on cardiovascular disease prevention. His research aims to develop tools which improve the targeting of preventative therapies such as antihypertensives and statins at patients with the most to gain.

He leads the Stratified Treatments Research Group at the Nuffield Department of Primary Care Health Sciences at the University of Oxford. His group is interested in developing prognostic models for treatment harms using data from large electronic health record databases. In addition he is interested in developing new strategies to deal with polypharmacy and currently leads a randomised controlled trial of antihypertensive deprescribing in patients over the age of 80 years.


Dr Laurie Tomlinson, London School of Hygiene and Tropical Medicine, UK

Laurie Tomlinson is a Wellcome and Intermediate Fellow and Associate Professor at the London School of Hygiene and Tropical Medicine as well as an honorary Consultant Nephrologist at Brighton and Sussex University Hospital. Her main research interest is the use of electronic health records to investigate kidney-related adverse events for prescribed medication.
Professor Izabella Uchmanowicz, Wroclaw Medical University, Poland

Prof. Izabella Uchmanowicz, RN, PhD, FESC - is a nurse, specialist of cardiology and geriatric nursing. She is a Board Member of the Association of Cardiovascular Nursing & Allied Professions within the European Society of Cardiology.
Currently employed at Wroclaw Medical University in Poland as a Professor, she is also a Head of the Faculty of Postgraduate Studies at the Public Health Department.
Her research is mostly devoted to heart failure and the problems of patients living with the disease, mainly self-care and adherence to medication. She is especially interested in studies of elderly people with cardiovascular disorders, and her main interests are frailty syndrome and nutritional problems within this population.
She is involved in the European project RANCARE (Rationing of Nursing Care) form COST. The overall aim of this Action is to facilitate discussion about rationing of nursing care based on a cross-national comparative approach with implications for practice and professional development. This will be achieved by advancing collaboration and networking, and by integrating different disciplines and approaches including nursing, ethics and moral philosophy, health care studies in general, economics and social policy.
Dr Carlos Valencia-Hernández, University College London, UK

Dr Valencia-Hernández holds an MD degree in Medicine from National University of Colombia.
He is currently a PhD student at University College London, researching on cardiovascular ageing, healthy ageing and longitudinal trajectories of biologic risk factors using data from the Whitehall II study.
His recent works study the relationship between arterial stiffness and hypertension.
Professor David Wheeler, University College London, UK

David is Professor of Kidney Medicine at University College London, UK and Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust. He is a clinician scientist interested in the complications of chronic kidney disease, specifically those that increase the burden of cardiovascular disease and/or accelerate progression of kidney failure. He has participated in the development and running of several large-scale clinical trials testing lipid lowering regimens, calcimimetics and sodium glucose cotransporter 2 inhibitors in patients chronic kidney disease.
Dr Maria-Christina Zennaro, French National Institute of Health and Medical Research, France

Maria-Christina Zennaro is Research Director at the French National Institute of Health and Medical Research (Inserm), head of the team “Genetic mechanisms of aldosterone related disorders” at the Paris Cardiovascular Research Center and associated investigator at the Genetics Department of the European Hospital Georges Pompidou (HEGP) in Paris, France.